NIVEN RALPH has filed 18 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 1400 shares of Jade Biosciences, Inc. ($JBIO) on February 05, 2024.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 1400 | $1.74 | 3,009.0000 | 0 | 87.01% | 0.00% |
| Feb. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 3200 | $2.14 | 6,209.0000 | 0 | 106.35% | 0.00% |
| Feb. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 4600 | $17.45 | 1,609.0000 | 0 | 74.09% | 0.00% |
| Feb. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 900 | $0.00 | 13,308.0000 | 0 | 6.33% | 0.00% |
| Feb. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 500 | $0.00 | 9,088.0000 | 0 | 5.21% | 0.00% |
| Feb. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 500 | $0.00 | 10,894.0000 | 0 | 4.39% | 0.00% |
| Feb. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 1200 | $0.00 | 34,908.0000 | 0 | 3.32% | 0.00% |
| Feb. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 1500 | $0.00 | 41,732.0000 | 0 | 3.47% | 0.00% |
| Jan. 22, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 66586 | $0.00 | 66,586.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 1400 | $1.74 | 3,009.0000 | 0 | 87.01% | 0.00% |
| Jan. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 3200 | $2.14 | 6,209.0000 | 0 | 106.35% | 0.00% |
| Jan. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2126 | $18.67 | 4,083.0000 | 0 | 34.24% | 0.00% |
| Jan. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2474 | $19.57 | 1,609.0000 | 0 | 60.59% | 0.00% |
| Jan. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 900 | $0.00 | 14,208.0000 | 0 | 5.96% | 0.00% |
| Jan. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 500 | $0.00 | 9,588.0000 | 0 | 4.96% | 0.00% |
| Jan. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 500 | $0.00 | 11,394.0000 | 0 | 4.20% | 0.00% |
| Jan. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 1200 | $0.00 | 36,108.0000 | 0 | 3.22% | 0.00% |
| Jan. 5, 2024 | Jade Biosciences, Inc. | $JBIO | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 1500 | $0.00 | 43,232.0000 | 0 | 3.35% | 0.00% |